· Event impact
Vanguard Health Care ETF (VHT) Outperforms SPDR Biotech (XBI) in Yield, Cost
Transmission path
Investors seeking broad healthcare exposure with lower costs and higher income may favor VHT, while those seeking higher growth potential and willing to accept higher volatility may prefer XBI. This highlights a divergence in investment strategies within the healthcare sector.
Market mechanism
Investors seeking broad healthcare exposure with lower costs and higher income may favor VHT, while those seeking higher growth potential and willing to accept higher volatility may prefer XBI. This highlights a divergence in investment strategies within the healthcare sector.
Extended read
A comparison between two prominent healthcare ETFs reveals distinct characteristics: The Vanguard Health Care ETF (VHT) provides broad exposure to the entire healthcare sector, featuring a low expense ratio of 0.09% and a higher dividend yield of 1.69%. In contrast, the SPDR S&P Biotech ETF (XBI) offers a more targeted focus on the biotechnology sub-sector, which typically entails higher volatility. Despite its higher costs and volatility, XBI has demonstrated significantly stronger recent 1-year returns, achieving 62.20% compared to VHT's 13.00%. This divergence underscores different risk-reward profiles for investors within the healthcare space.
Exposed assets
VHT · XBI
Continuous event tracking, options routing, and portfolio overlap for this event and the assumptions it moves live inside Market Ontology. Start a trial →